论文部分内容阅读
本文对我院心内科在１９９１－１９９５年间施行静脉溶栓治疗的１００例急性心肌梗塞病例的临床资料进行了分析总结，结果：血管通畅率６１％，其中尿激酶５７％，链激酶７１％；总死亡率６％，其中血管再通组和未通组分别为１．６％或１２．８％（Ｐ＜０．００１）；再通组的心衰和严重室性心律失常的发生率均明显低于未通组，且左室射血分数明显高于未通组；溶栓在梗塞发作６小时内开始者其通畅率远远大于６－１２小时者，我们认为在严格排除禁忌证，确定适应证后，溶栓治疗应尽早开始；同时严密心电血压监测，以增加成功率和安全性。
In this paper, clinical data of 100 cases of acute myocardial infarction treated by intravenous thrombolysis in the Department of Cardiology of our hospital during 1991-1995 were analyzed and summarized. Results: Vascular patency rate was 61%, including 57% of urokinase and 71% of streptokinase; The overall mortality rate was 6%, of which 1.6% or 12.8% in the recanalization group and the non-recanalization group, respectively (P <0.001). The incidence of heart failure and severe ventricular arrhythmia in the recanalization group was Significantly lower than the non-pass group, and left ventricular ejection fraction was significantly higher than the failed group; thrombolytic initiation within 6 hours of onset of the patency rate is much greater than 6-12 hours, we believe that the strict exclusion of contraindications, After identifying indications, thrombolytic therapy should start as soon as possible; at the same time close monitoring of ECG, to increase the success rate and safety.